These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3157546)

  • 21. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.
    Amatayakul K; Sivassomboon B; Singkamani R
    Contraception; 1980 Mar; 21(3):283-97. PubMed ID: 6446443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
    Amatayakul K; Suriyanon V
    Int J Gynaecol Obstet; 1985 Oct; 23(5):361-8. PubMed ID: 2866986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medroxyprogesterone acetate [Depo Provera] injections. Development of striae.
    Gupta M
    Br J Fam Plann; 2000 Apr; 26(2):104-5. PubMed ID: 10773604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of Depo-Provera in East London.
    Savage W
    Fertil Contracept; 1978 Jul; 2(3):41-7. PubMed ID: 12260723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of Depo-Provera on serum protein levels in Nigerian women.
    Fajumi JO
    J Steroid Biochem; 1984 Feb; 20(2):581-3. PubMed ID: 6231426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.
    Fotherby K; Saxena BN; Shrimanker K; Hingorani V; Takker D; Diczfalusy E; Landgren BM
    Fertil Steril; 1980 Aug; 34(2):131-9. PubMed ID: 7409232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In utero exposure to steroid contraceptives and survival during infancy.
    Gray RH; Pardthaisong T
    Am J Epidemiol; 1991 Oct; 134(8):804-11. PubMed ID: 1835283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy.
    Zacharias S; Aguilera E; Assenzo JR; Zanartu J
    Contraception; 1986 Mar; 33(3):203-13. PubMed ID: 2941236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    Dahlberg K
    Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemics.
    Netw Res Triangle Park N C; 1985; 6(3):1-3. PubMed ID: 12280131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressive symptoms and Depo-Provera.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Davidson A; Rulin M; Heartwell S
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic effects of depot-medroxyprogesterone acetate in long-term users: a cross-sectional study.
    Virutamasen P; Wongsrichanalai C; Tangkeo P; Nitichai Y; Rienprayoon D
    Int J Gynaecol Obstet; 1986 Aug; 24(4):291-6. PubMed ID: 2878838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
    Kuhn L; Denny L; Pollack AE; Wright TC
    Contraception; 1999 Jun; 59(6):363-7. PubMed ID: 10518230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depo-Provera: just another contraceptive?
    Jones M
    Fertil Contracept; 1978 Apr; 2(2):26-9. PubMed ID: 12336094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate.
    Jimenez J; Ochoa M; Soler MP; Portales P
    Contraception; 1984 Dec; 30(6):523-33. PubMed ID: 6241560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
    Petta CA; Faúndes A; Dunson TR; Ramos M; DeLucio M; Faúndes D; Bahamondes L
    Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.